HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Efalizumab-associated papular psoriasis: an adverse reaction to efalizumab in three cases.

Abstract
Efalizumab-associated papular psoriasis is a common adverse event caused by efelizumab therapy. This clinical manifestation is characterized by a transient popular eruption localized especially on the flexural areas and on the back. We report three cases of efalizumab-associated papular psoriasis.
AuthorsAngela Antonucci, Federico Bardazzi, Riccardo Balestri, Annalisa Patrizi
JournalThe Journal of dermatological treatment (J Dermatolog Treat) Vol. 20 Issue 1 Pg. 61-2 ( 2009) ISSN: 1471-1753 [Electronic] England
PMID18618361 (Publication Type: Journal Article)
Chemical References
  • Adrenal Cortex Hormones
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • efalizumab
Topics
  • Adrenal Cortex Hormones (therapeutic use)
  • Adult
  • Antibodies, Monoclonal (adverse effects, therapeutic use)
  • Antibodies, Monoclonal, Humanized
  • Axilla
  • Biopsy, Needle
  • Dose-Response Relationship, Drug
  • Drug Eruptions (drug therapy, etiology, pathology)
  • Follow-Up Studies
  • Humans
  • Immunohistochemistry
  • Male
  • Middle Aged
  • Psoriasis (chemically induced, drug therapy, pathology)
  • Risk Assessment
  • Sampling Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: